MCA logo

PUBLIC PORTAL

invest selangor

MEDICALLY REVIEWED

The FDA has Granted Full Approval to Pembrolizumab for the Treatment of Unresectable Or Msi-H Or Dmmr Solid Tumour

FDA
This marks the first-ever FDA approval for immunotherapy based on a predictive biomarker, regardless of solid tumour type.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: